Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2025-12-31 @ 9:36 PM
Study NCT ID:
NCT06613100
Status:
RECRUITING
Last Update Posted:
2025-12-01
First Post:
2024-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01-23
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-23
First Submit QC Date:
None
Study First Post Date:
2024-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED